Skip to main content
Signal8

Mintz Paul

SEC insider (Form 3/4/5 filer). CIK 0001480208. Director at Nuo Therapeutics, Inc. (AURX). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in HOUSTON, TX.

Companies Mintz Paul has filed insider reports for

  • Nuo Therapeutics, Inc. (AURX): Director
Mintz Paul profile photo

Mintz Paul

CIK: 0001480208

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (57.1%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nuo Therapeutics, Inc. logo
AURX

Nuo Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Jun 29, 2026
    Award

    Option to Purchase Common Stock

    Direct
    30K shares-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Dec 9, 2025
    Exercise
    Direct
    50K shares at avg. $0.40$20K
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Dec 9, 2025
    Tax Payment
    Direct
    9.1K shares at avg. $2.20$20K
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Aug 1, 2025
    Exercise
    Direct
    87.5K shares at avg. $0.40$35K
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Aug 1, 2025
    Tax Payment
    Direct
    20.1K shares at avg. $1.74$35K
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Dec 31, 2018
    Exercise

    Option to purchase common stock

    Direct
    50K shares-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Aug 9, 2018
    Exercise

    Option to purchase common stock

    Direct
    87.5K shares-

1-7 of 7